Lisata Therapeutics
LSTA1.0493.76% ( -0.041 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Lisata Therapeutics(LSTA) the EBIT is -4.942 M (+15.48%);the EPS is -0.498 (+9.24%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B15.48%
----
----
EPS
-0.49849.24%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf